CATEGORIES

Nipro partners with FPT Medicare to develop IOMT in Vietnam

Nipro, a multinational medical corporation from Japan, has recently partnered with Vietnam-based FPT Telecom's FPT Medicare on a strategic cooperation agreement to deliver digital medical devices with international standards and affordability.

China's MGI Tech takes cutting-edge DNA, Cell and Spatial Omics capabilities to Australia

MGI Australia, a subsidiary of China headquartered MGI Tech Co., a global leader in life science technology, has announced a substantial expansion of its Brisbane Customer Experience Centre (CEC), now providing Australian and New Zealand researchers first access to MGI's cutting-edge DNA, Cell and Spatial Omics (DCS) capabilities.

GC Biopharma establishes mRNA production facility in Korea

GC Biopharma, a South Korean biopharmaceutical company, has completed the construction of mRNA (messenger ribonucleic acid) production facility in its own vaccine production plant in Hwasun, Jeollanam-do, Korea, and will soon start the operation.

GHIT Fund injects $8.8M in new drug development projects for malaria

The Global Health Innovative Technology (GHIT) Fund, headquartered in Japan, has announced an investment of approximately 1.3 billion yen ($8.8 million) for the development of new drugs for malaria and Chagas disease

MTal unveils India's historic $464M medtech FDI leap

India has witnessed a recordbreaking surge of $464 million in foreign investments in medtech in the first 3 quarters, said the Medical Technology Association of India (MTI), which represents leading researchbased medical technology companies with a large footprint in manufacturing and training in India.

ADB provides $650M to support upgrading Indonesia's healthcare facilities and labs

The Asian Development Bank (ADB) has approved a $650 million investment loan to Indonesia to upgrade and enhance primary healthcare facilities and public health laboratories nationwide to improve prevention, detection, and treatment of communicable diseases, non-communicable diseases, and other health conditions

WHO & India ink Traditional and Complementary Medicine Project Collaboration Agreement'

The Ministry of Ayush, Government of India, and World Health Organization (WHO) have signed a Traditional and Complementary Medicine 'Project Collaboration Agreement' in Geneva.

NZ to design cancer control programme

New Zealand’s Ministry of Health’s Polynesian Health Corridors (PHC) programme is working with partners to design a multi-year cancer control programme to improve cancer outcomes in Polynesia.

Australia launches first National Health & Climate Strategy

The Australian government has launched Australia's first National Health and Climate Strategy that is aimed at ensuring the health system can meet the challenges of climate change.

Taiwan partners with US to develop digital health ecosystem

The Healthcare Information and Management Systems Society, US and the National Health Insurance Administration (NHIA), an agency under the Ministry of Health and Welfare of Taiwan, have formed an agreement to drive digital transformation in population health, digital capacity building, cybersecurity resilience and workforce development.

INDIA'S CDMO ASCENSION

We are ushering in 2024 with a good development for the Indian pharmaceutical sector.

New research unveils innovative mosquito control strategies in India

Researchers from the Indian Institute of Technology (IIT) Mandi, the Institute for Stem Cell Science and Regenerative Medicine (inStem) in Bengaluru, have discovered the biochemical processes that enable the eggs of the dengue-causing mosquito to survive harsh conditions and rejuvenate when favourable conditions return.

Singapore offers innovative magnetic gel to heal diabetic wounds faster

Diabetic patients, whose natural wound-healing capabilities are compromised, often develop chronic wounds that are slow to heal.

Korea develops metal-enhanced fluorescence probes for influenza A virus detection

In recent years, fluorescence-based lateral flow immunoassay (LFI) has gained popularity as a diagnostic tool for viral detection.

Hong Kong designs multimodal robot for post-stroke ankle, foot tele-rehabilitation

The Hong Kong Polytechnic University (PolyU) has achieved another breakthrough in rehabilitation device development.

PolyU, Hefei Luyang establish innovation research institute

The Hong Kong Polytechnic University (PolyU) and the Hefei Luyang government in China have reached an agreement to jointly establish the PolyU-Hefei Technology and Innovation Research Institute, with the aim of fostering in-depth and effective collaboration in industry, academia and research and cultivating talents.

Porton Advanced, BioMap jointly develop gene therapies based on AAV vectors

China-based startup Porton Advanced has announced the establishment of a strategic partnership with BioMap.

Smith+Nephew introduces REGENETEN Bioinductive Implant in Japan

British medtech company Smith+Nephew has announced the launch of its REGENETEN Bioinductive Implant allowing access to thousands of patients in Japan.

East Ventures opens first healthcare fund of $30M in Indonesia

East Ventures, a pioneering and leading venture capital firm in Indonesia and Southeast Asia, has announced the firm’s first healthcare-focused fund with the amount of $30 million, which is dedicated to supporting innovative healthcare solutions in Indonesia.

New Zealand launches national polio response framework

The Ministry of Health in New Zealand has published a new National Poliomyelitis Response Framework, responding to the increased risk of poliovirus globally.

India announces women leadership in STEM programme

WOMEN LEADERSHIP IN STEM

Australia releases landmark cancer plan to improve screening, treatment

The Australian Government has released the landmark Australian Cancer Plan, which aims to improve prevention, screening, treatment, and management of all cancers for all people in Australia regardless of their background or where they live.

Singapore extends cooperation with China in traditional chinese medicine

Singapore will further its cooperation in several areas of Traditional Chinese Medicine (TCM) with the People’s Republic of China (PRC), with the signing of the 7th Plan of Cooperation (POC) in TCM between Singapore’s Ministry of Health (MoH) and the PRC’s National Administration of TCM (NATCM) recently.

PROMOTING INDIAN TRADITIONAL MEDICINE

Myanmar and India have been planning joint efforts for the promotion of traditional healthcare systems and medicine in both countries. Recently, in Myanmar, India proposed to set up a Joint Working Group (JWG) to promote cooperation between the two countries in teaching and researching the traditional system of medicine. A bilateral meeting was held in March 2023 in India where possibilities of cooperation in the field of traditional medicines were discussed. Later, in August, a memorandum of understanding (MoU) was signed between the countries in New Delhi on cooperation in the field of traditional medicine when U Kyaw Tin, Myanmar’s Minister of State for Foreign Affairs, was visiting India.

Biopharma's Evolution and Future Resilience in Asia

As the world emerges from the COVID-19 crisis, the global biopharma industry remains under spotlight. Recent advancements in the sector such as MRNA-based vaccines, use of artificial intelligence Al) in drug discovery, exploration of cell and gene therapies, have the potential to reshape lives, offering hope in the face of looming threats such as pandemics and antimicrobial resistance. Based on five pillars supply chain resilience, talent pool, R&D ecosystem, manufacturing agility, and government policy and regulation, Cytiva has unveiled the findings of the 2023 Global Biopharma Resilience Index, to help us identify the gaps in the industry now, and how to mitigate current challenges for a stronger future within Asia Pacific and Southeast Asia.

Can Cutting-edge Tech Reduce Rising CVD Burden?

Each year World Heart Day is observed to increase awareness about cardiovascular diseases (CVDs), after all defeating them is something that matters to every beating heart. CVDs are disorders of the heart and blood vessels and are often referred to as “silent killers” because most of the patients with underlying heart ailments do not exhibit any obvious symptoms. Development and deployment of cutting-edge technologies backed by requisite government policy support and direction will help in bolstering the fight against CVDs and thus improving the quality of the individuals’ heart and also their lives. Let’s take a closer look.

Focusing on Women's Cancers

Breast and cervical cancer are pressing threats to women and health systems in the Asia Pacific APAC) region. A new multisectoral collaboration and a powerful analysis of six countries’ breast and cervical cancer prevention and care capacity are generating momentum to save lives and contribute to a global health movement.

"The cancer diagnostics industry is on the cusp of substantial growth, attributed to an aging population"

eadquartered in California, USA, Harae Dx, H a medical diagnostics company is all set to introduce the next generation Artificial Intelligence AI) enabled automated multi-cancer early detection system in India, China and the US in three years-time period. Harae Dx has already secured seed funding from global investor SOSV and is in the process of securing Series A funding of 12 million. The company holds strategic patents in its core technology platform, and the development and manufacturing of the entire diagnostics system will be executed through strategic partnerships using an outsourced model. In an exclusive interview with BioSpectrum Dr Nitin Malekar, Director, Harae Dx Inc., shared his views on the effectiveness of the new technologies being offered and regulatory challenges. Edited excerpts;

Pharma Heads Pass Leadership Baton

The pharmaceutical industry is evaluating and adapting to the Great Reset, set in motion back in 2020. One key strategy in this regard has been the change of management structure, with several high-profile leadership changes in 2023. As the euphoria of pandemic-induced record revenues subsided in 2023, the pharmaceutical industry had to reevaluate its strategies and has undergone significant structural changes. Companies adapted their approaches, implementing measures such as job cuts, mergers and acquisitions M&A), and a comprehensive overhaul of top management to navigate the evolving landscape effectively. Big Pharma elites, including Pfizer, Sanofi, Novartis, Astellas, among others, have announced a slew of leadership changes in recent times. Let’s explore these further.

How has 2023 panned out for the life sciences industry in Asia Pacific?

Many of the trends in 2023 in life sciences in Asia Pacific were predicted, but there have been some unexpected events, which have caught market participants off-guard. It’s been the year of the expected and the surprises.